Journal
MOLECULAR BIOTECHNOLOGY
Volume 64, Issue 6, Pages 660-669Publisher
SPRINGERNATURE
DOI: 10.1007/s12033-022-00452-w
Keywords
Breast cancer; Prognosis; Cellular function
Ask authors/readers for more resources
In this study, the biomarker potential and cellular function of long non-coding RNA PPP1R26-AS1 were investigated in breast cancer. The results showed that PPP1R26-AS1 was highly expressed in breast tissues and cell lines and its upregulation was associated with certain clinical parameters and shorter overall survival in breast cancer patients. Knockdown of PPP1R26-AS1 significantly reduced cell proliferation, migration, and invasion. Additionally, PPP1R26-AS1 was found to act as a ceRNA binding with miR-1226-3p in breast cancer.
Breast cancer has become the most leading diagnosed tumor worldwide in 2020. In this study, the biomarker potential and influence on the cellular function of lncRNA PPP1R26-AS1 was investigated in breast cancer. Expression levels of lncRNA PPP1R26-AS1 in breast tissues and cells were detected by RT-qPCR. Association between lncRNA PPP1R26-AS1 level and clinical parameters was investigated by Chi-square analysis. The prognostic potential was assessed by Kaplan-Meier and multivariate Cox regression analysis. Knockdown of lncRNA PPP1R26-AS1 was subjected to study the effect on cell proliferation, invasion, and migration by CCK-8 and transwell assay. The bind between PPP1R26-AS1 and miR-1226-3p was investigated. LncRNA PPP1R26-AS1 was highly expressed in breast tissues and cell lines. This upregulation was correlated with pTNM, positive ER status, luminal B subtype, positive nodal status, and shorter overall survival in breast cancer patients. Significant decreases in proliferation, migration, and invasion activity were observed upon knockdown of lncRNA PPP1R26-AS1. lncRNA PPP1R26-AS1 could act as ceRNA to bind with miR-1226-3p in breast cancer. LncRNA PPP1R26-AS1, as oncogenic lncRNA, could provide a new perspective on the development of prognostic biomarkers and a new approach in tailoring the treatment personalized in breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available